{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:07:51Z","timestamp":1779149271315,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-44049-8","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T14:03:19Z","timestamp":1775052199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Visual field progression in varying severities of treated patients with primary angle closure glaucoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Shayne S.","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tan See","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimna","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stella Jinran","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaila","family":"Boh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronnie","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mani","family":"Baskaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina T.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamira","family":"Perera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tin","family":"Aung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monisha Esther","family":"Nongpiur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"issue":"2","key":"44049_CR1","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","volume":"9","author":"JD Steinmetz","year":"2021","unstructured":"Steinmetz, J. D. et al. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: The Right to Sight: An analysis for the Global Burden of Disease Study. Lancet Glob. Health 9(2), e144\u2013e160. https:\/\/doi.org\/10.1016\/S2214-109X(20)30489-7 (2021).","journal-title":"Lancet Glob. Health"},{"issue":"11","key":"44049_CR2","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"YC Tham","year":"2014","unstructured":"Tham, Y. C. et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040. Ophthalmology 121(11), 2081\u20132090. https:\/\/doi.org\/10.1016\/j.ophtha.2014.05.013 (2014).","journal-title":"Ophthalmology"},{"issue":"3","key":"44049_CR3","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"HA Quigley","year":"2006","unstructured":"Quigley, H. A. The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol. 90(3), 262\u2013267. https:\/\/doi.org\/10.1136\/bjo.2005.081224 (2006).","journal-title":"Br. J. Ophthalmol."},{"issue":"7","key":"44049_CR4","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/ceo.14402","volume":"52","author":"SS Tan","year":"2024","unstructured":"Tan, S. S., Tun, T. A., Aung, T. & Nongpiur, M. E. Comparison of intraocular pressure and anterior segment parameters in subjects with asymmetrical primary angle closure disease. Clin. Exp. Ophthalmol. 52(7), 724\u2013731. https:\/\/doi.org\/10.1111\/ceo.14402 (2024).","journal-title":"Clin. Exp. Ophthalmol."},{"issue":"11","key":"44049_CR5","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1038\/s41433-021-01802-9","volume":"36","author":"R George","year":"2022","unstructured":"George, R., Panda, S. & Vijaya, L. Blindness in glaucoma: Primary open-angle glaucoma versus primary angle-closure glaucoma-a meta-analysis. Eye 36(11), 2099\u20132105. https:\/\/doi.org\/10.1038\/s41433-021-01802-9 (2022).","journal-title":"Eye"},{"issue":"12","key":"44049_CR6","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1016\/s0161-6420(00)00385-7","volume":"107","author":"Z Alsagoff","year":"2000","unstructured":"Alsagoff, Z., Aung, T., Ang, L. P. & Chew, P. T. Long-term clinical course of primary angle-closure glaucoma in an Asian population. Ophthalmology 107(12), 2300\u20132304. https:\/\/doi.org\/10.1016\/s0161-6420(00)00385-7 (2000).","journal-title":"Ophthalmology"},{"issue":"4","key":"44049_CR7","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0197-2456(94)90046-9","volume":"15","author":"The AGIS Investigators","year":"1994","unstructured":"The AGIS Investigators. The advanced glaucoma intervention study (AGIS): 1. Study design and methods and baseline characteristics of study patients. Control. Clin. Trials 15(4), 299\u2013325. https:\/\/doi.org\/10.1016\/0197-2456(94)90046-9 (1994).","journal-title":"Control. Clin. Trials"},{"issue":"3","key":"44049_CR8","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ajo.2011.02.023","volume":"152","author":"DTL Quek","year":"2011","unstructured":"Quek, D. T. L. et al. Blindness and long-term progression of visual field defects in Chinese patients with primary angle-closure glaucoma. Am. J. Ophthalmol. 152(3), 463\u2013469. https:\/\/doi.org\/10.1016\/j.ajo.2011.02.023 (2011).","journal-title":"Am. J. Ophthalmol."},{"issue":"4","key":"44049_CR9","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","volume":"130","author":"The AGIS Investigators","year":"2000","unstructured":"The AGIS Investigators. The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am. J. Ophthalmol. 130(4), 429\u2013440. https:\/\/doi.org\/10.1016\/S0002-9394(00)00538-9 (2000).","journal-title":"Am. J. Ophthalmol."},{"issue":"2","key":"44049_CR10","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ophtha.2008.08.051","volume":"116","author":"DC Musch","year":"2009","unstructured":"Musch, D. C. et al. Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors. Ophthalmology 116(2), 200\u2013207. https:\/\/doi.org\/10.1016\/j.ophtha.2008.08.051 (2009).","journal-title":"Ophthalmology"},{"issue":"7","key":"44049_CR11","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.ophtha.2017.02.027","volume":"124","author":"S Verma","year":"2017","unstructured":"Verma, S. et al. Visual field progression in patients with primary angle-closure glaucoma using pointwise linear regression analysis. Ophthalmology 124(7), 1065\u20131071. https:\/\/doi.org\/10.1016\/j.ophtha.2017.02.027 (2017).","journal-title":"Ophthalmology"},{"issue":"9","key":"44049_CR12","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.66.9.59","volume":"66","author":"R Shen","year":"2025","unstructured":"Shen, R. et al. Risk factors for visual field progression in primary angle closure disease over 10 years: The CUPAL Study. Invest. Ophthalmol. Vis. Sci. 66(9), 59. https:\/\/doi.org\/10.1167\/iovs.66.9.59 (2025).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"44049_CR13","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ajo.2019.02.015","volume":"202","author":"X Zhang","year":"2019","unstructured":"Zhang, X. et al. Predictive factors for the rate of visual field progression in the Advanced Imaging for Glaucoma Study. Am. J. Ophthalmol. 202, 62\u201371. https:\/\/doi.org\/10.1016\/j.ajo.2019.02.015 (2019).","journal-title":"Am. J. Ophthalmol."},{"issue":"5","key":"44049_CR14","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/ng.3540","volume":"48","author":"CC Khor","year":"2016","unstructured":"Khor, C. C. et al. Genome-wide association study identifies five new susceptibility loci for primary angle closure glaucoma. Nat. Genet. 48(5), 556\u2013562. https:\/\/doi.org\/10.1038\/ng.3540 (2016).","journal-title":"Nat. Genet."},{"issue":"10","key":"44049_CR15","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/ng.2390","volume":"44","author":"EN Vithana","year":"2012","unstructured":"Vithana, E. N. et al. Genome-wide association analyses identify three new susceptibility loci for primary angle closure glaucoma. Nat. Genet. 44(10), 1142\u20131146. https:\/\/doi.org\/10.1038\/ng.2390 (2012).","journal-title":"Nat. Genet."},{"issue":"2","key":"44049_CR16","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1136\/bjo.86.2.238","volume":"86","author":"PJ Foster","year":"2002","unstructured":"Foster, P. J. The definition and classification of glaucoma in prevalence surveys. Br. J. Ophthalmol. 86(2), 238\u2013242. https:\/\/doi.org\/10.1136\/bjo.86.2.238 (2002).","journal-title":"Br. J. Ophthalmol."},{"issue":"7","key":"44049_CR17","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1167\/iovs.14-14643","volume":"55","author":"BC Chauhan","year":"2014","unstructured":"Chauhan, B. C. et al. Rates of glaucomatous visual field change in a large clinical population. Invest Ophthalmol Vis Sci 55(7), 4135\u20134143. https:\/\/doi.org\/10.1167\/iovs.14-14643 (2014).","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"44049_CR18","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.ophtha.2023.01.008","volume":"130","author":"AB Jackson","year":"2023","unstructured":"Jackson, A. B. et al. Fast progressors in glaucoma: Prevalence based on global and central visual field loss. Ophthalmology 130(5), 462\u2013468. https:\/\/doi.org\/10.1016\/j.ophtha.2023.01.008 (2023).","journal-title":"Ophthalmology"},{"issue":"5","key":"44049_CR19","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1755-3768.2012.02492.x","volume":"91","author":"A Heijl","year":"2013","unstructured":"Heijl, A., Buchholz, P., Norrgren, G. & Bengtsson, B. Rates of visual field progression in clinical glaucoma care. Acta Ophthalmol. (Copenh). 91 (5), 406\u2013412. https:\/\/doi.org\/10.1111\/j.1755-3768.2012.02492.x (2013).","journal-title":"Acta Ophthalmol. (Copenh)"},{"issue":"10","key":"44049_CR20","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/j.ophtha.2011.03.012","volume":"118","author":"MW Marcus","year":"2011","unstructured":"Marcus, M. W., De Vries, M. M., Montolio, F. G. J. & Jansonius, N. M. Myopia as a risk factor for open-angle glaucoma: A systematic review and meta-analysis. Ophthalmology 118(10), 1989-1994e.e2. https:\/\/doi.org\/10.1016\/j.ophtha.2011.03.012 (2011).","journal-title":"Ophthalmology"},{"issue":"3","key":"44049_CR21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s13167-019-00174-1","volume":"10","author":"S Li","year":"2019","unstructured":"Li, S. et al. Relationship between ocular biometry and severity of primary angle-closure glaucoma: Relevance for predictive, preventive, and personalized medicine. EPMA Journal 10(3), 261\u2013271. https:\/\/doi.org\/10.1007\/s13167-019-00174-1 (2019).","journal-title":"EPMA Journal"},{"issue":"1","key":"44049_CR22","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1167\/iovs.17-22949","volume":"59","author":"M Yanagisawa","year":"2018","unstructured":"Yanagisawa, M. et al. Changes in axial length and progression of visual field damage in glaucoma. Investig Opthalmol. Vis. Sci. 59(1), 407. https:\/\/doi.org\/10.1167\/iovs.17-22949 (2018).","journal-title":"Investig Opthalmol. Vis. Sci."},{"issue":"4","key":"44049_CR23","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1167\/iovs.15-18529","volume":"57","author":"JB Jonas","year":"2016","unstructured":"Jonas, J. B. et al. Retinal thickness and axial length. Investig. Opthalmol. Vis. Sci. 57(4), 1791. https:\/\/doi.org\/10.1167\/iovs.15-18529 (2016).","journal-title":"Investig. Opthalmol. Vis. Sci."},{"issue":"1","key":"44049_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/archopht.121.1.48","volume":"121","author":"MC Leske","year":"2003","unstructured":"Leske, M. C. Factors for glaucoma progression and the effect of treatment: The Early Manifest Glaucoma Trial. Arch Ophthalmol 121(1), 48. https:\/\/doi.org\/10.1001\/archopht.121.1.48 (2003).","journal-title":"Arch Ophthalmol"},{"issue":"10052","key":"44049_CR25","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0140-6736(16)30956-4","volume":"388","author":"A Azuara-Blanco","year":"2016","unstructured":"Azuara-Blanco, A. et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): A randomised controlled trial. Lancet 388(10052), 1389\u20131397. https:\/\/doi.org\/10.1016\/S0140-6736(16)30956-4 (2016).","journal-title":"Lancet"},{"issue":"4","key":"44049_CR26","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S3139","volume":"2","author":"K Kooner","year":"2008","unstructured":"Kooner, K. Risk factors for progression to blindness in high tension primary open angle glaucoma: Comparison of blind and nonblind subjects. Clin Ophthalmol 757. https:\/\/doi.org\/10.2147\/OPTH.S3139 (2008).","journal-title":"Clin Ophthalmol"},{"issue":"9","key":"44049_CR27","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1097\/IJG.0b013e3181ca7de9","volume":"19","author":"R Sihota","year":"2010","unstructured":"Sihota, R., Rao, A., Gupta, V., Srinivasan, G. & Sharma, A. Progression in primary angle closure eyes. J. Glaucoma 19(9), 632\u2013636. https:\/\/doi.org\/10.1097\/IJG.0b013e3181ca7de9 (2010).","journal-title":"J. Glaucoma"},{"key":"44049_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ajo.2021.08.004","volume":"234","author":"CY Cheung","year":"2022","unstructured":"Cheung, C. Y. et al. Intraocular pressure control predicts retinal nerve fiber layer thinning in primary angle closure disease: The CUPAL Study. Am. J. Ophthalmol. 234, 205\u2013214. https:\/\/doi.org\/10.1016\/j.ajo.2021.08.004 (2022).","journal-title":"Am. J. Ophthalmol."},{"issue":"6","key":"44049_CR29","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1089\/jop.2006.0142","volume":"23","author":"S Hong","year":"2007","unstructured":"Hong, S., Kim, C. Y. & Seong, G. J. Long-term intraocular pressure fluctuation and visual field progression in glaucoma patients with low intraocular pressure after post-trabeculectomy phacoemulsification. J. Ocul. Pharmacol. Ther. 23(6), 571\u2013576. https:\/\/doi.org\/10.1089\/jop.2006.0142 (2007).","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"44049_CR30","unstructured":"Exceptional Surveillance of Glaucoma: Diagnosis and Management (NICE Guideline NG81). National Institute for Health and Care Excellence (NICE). (accessed September 5, 2025). (2019). http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK552251\/"},{"key":"44049_CR31","doi-asserted-by":"publisher","unstructured":"European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition - Chap. 3: Treatment principles and options Supported by the EGS Foundation. Br J Ophthalmol.\u00a0101 (6), 130\u2013195 (2017). https:\/\/doi.org\/10.1136\/bjophthalmol-2016-EGSguideline.003","DOI":"10.1136\/bjophthalmol-2016-EGSguideline.003"},{"key":"44049_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2015.00112","volume":"6","author":"JC Kohn","year":"2015","unstructured":"Kohn, J. C., Lampi, M. C. & Reinhart-King, C. A. Age-related vascular stiffening: Causes and consequences. Front. Genet. 6, 112. https:\/\/doi.org\/10.3389\/fgene.2015.00112 (2015).","journal-title":"Front. Genet."},{"issue":"1","key":"44049_CR33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1089\/wound.2011.0328","volume":"2","author":"MJ Sherratt","year":"2013","unstructured":"Sherratt, M. J. Age-related tissue stiffening: Cause and effect. Adv. Wound Care 2(1), 11\u201317. https:\/\/doi.org\/10.1089\/wound.2011.0328 (2013).","journal-title":"Adv. Wound Care"},{"key":"44049_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2024.12.034","author":"FA Medeiros","year":"2024","unstructured":"Medeiros, F. A., Varma, A., Jammal, A. A., Tseng, H. & Scott, W. K. Accelerated epigenetic aging is associated with faster glaucoma progression. Ophthalmology https:\/\/doi.org\/10.1016\/j.ophtha.2024.12.034 (2024).","journal-title":"Ophthalmology"},{"issue":"2","key":"44049_CR35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.exer.2010.09.002","volume":"93","author":"D Schmidl","year":"2011","unstructured":"Schmidl, D., Garhofer, G. & Schmetterer, L. The complex interaction between ocular perfusion pressure and ocular blood flow \u2013 Relevance for glaucoma. Exp. Eye Res. 93 (2), 141\u2013155. https:\/\/doi.org\/10.1016\/j.exer.2010.09.002 (2011).","journal-title":"Exp. Eye Res."},{"issue":"1","key":"44049_CR36","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.coph.2012.09.003","volume":"13","author":"AP Cherecheanu","year":"2013","unstructured":"Cherecheanu, A. P., Garhofer, G., Schmidl, D., Werkmeister, R. & Schmetterer, L. Ocular perfusion pressure and ocular blood flow in glaucoma. Curr. Opin. Pharmacol. 13(1), 36\u201342. https:\/\/doi.org\/10.1016\/j.coph.2012.09.003 (2013).","journal-title":"Curr. Opin. Pharmacol."},{"issue":"4","key":"44049_CR37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/IJG.0000000000001985","volume":"31","author":"A Miki","year":"2022","unstructured":"Miki, A. et al. Evaluating visual field progression in advanced glaucoma using trend analysis of targeted mean total deviation. J Glaucoma 31(4), 235\u2013241. https:\/\/doi.org\/10.1097\/IJG.0000000000001985 (2022).","journal-title":"J Glaucoma"},{"key":"44049_CR38","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.2147\/OPTH.S475812","volume":"18","author":"K Malewicz","year":"2024","unstructured":"Malewicz, K., Pender, A., Chabowski, M. & Jankowska-Pola\u0144ska, B. Impact of sociodemographic and psychological factors on adherence to glaucoma treatment - A cross-sectional study. Clin. Ophthalmol. Auckl. NZ 18, 2503\u20132520. https:\/\/doi.org\/10.2147\/OPTH.S475812 (2024).","journal-title":"Clin. Ophthalmol. Auckl. NZ"},{"issue":"1","key":"44049_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-025-13020-0","volume":"25","author":"DS Rata Mohan","year":"2025","unstructured":"Rata Mohan, D. S. et al. Gender differences in health-seeking behaviour: insights from the National Health and Morbidity Survey 2019. BMC Health Serv Res 25(1), 900. https:\/\/doi.org\/10.1186\/s12913-025-13020-0 (2025).","journal-title":"BMC Health Serv Res"},{"issue":"9","key":"44049_CR40","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/IJG.0b013e31821db409","volume":"21","author":"FA Folgar","year":"2012","unstructured":"Folgar, F. A. et al. Effect of successful and partly successful filtering surgery on the velocity of glaucomatous visual field progression. J Glaucoma 21(9), 615\u2013618. https:\/\/doi.org\/10.1097\/IJG.0b013e31821db409 (2012).","journal-title":"J Glaucoma"},{"issue":"7","key":"44049_CR41","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1136\/bjophthalmol-2016-308948","volume":"101","author":"C Baril","year":"2017","unstructured":"Baril, C. et al. Rates of glaucomatous visual field change after trabeculectomy. Br J Ophthalmol 101(7), 874\u2013878. https:\/\/doi.org\/10.1136\/bjophthalmol-2016-308948 (2017).","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"44049_CR42","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1001\/jamaophthalmol.2014.4237","volume":"133","author":"LJ Saunders","year":"2015","unstructured":"Saunders, L. J., Russell, R. A. & Crabb, D. P. Measurement precision in a series of visual fields acquired by the standard and fast versions of the Swedish Interactive Thresholding Algorithm: Analysis of large-scale data from clinics. JAMA Ophthalmol 133(1), 74\u201380. https:\/\/doi.org\/10.1001\/jamaophthalmol.2014.4237 (2015).","journal-title":"JAMA Ophthalmol"},{"key":"44049_CR43","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ajo.2016.05.003","volume":"168","author":"M Sullivan-Mee","year":"2016","unstructured":"Sullivan-Mee, M., Karin Tran, M. T., Pensyl, D., Tsan, G. & Katiyar, S. Prevalence, features, and severity of glaucomatous visual field loss measured with the 10\u2009\u2212\u20092 Achromatic Threshold Visual Field Test. Am J Ophthalmol 168, 40\u201351. https:\/\/doi.org\/10.1016\/j.ajo.2016.05.003 (2016).","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"44049_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-91173-8","volume":"11","author":"J Jiang","year":"2021","unstructured":"Jiang, J. et al. Intraocular asymmetry of visual field defects in primary angle-closure glaucoma, high-tension glaucoma, and normal-tension glaucoma in a Chinese population. Sci Rep 11(1), 11674. https:\/\/doi.org\/10.1038\/s41598-021-91173-8 (2021).","journal-title":"Sci Rep"},{"key":"44049_CR45","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ajo.2022.05.023","volume":"242","author":"OA Halawa","year":"2022","unstructured":"Halawa, O. A. et al. Race and ethnicity differences in disease severity and visual field progression among glaucoma patients. Am. J. Ophthalmol. 242, 69\u201376. https:\/\/doi.org\/10.1016\/j.ajo.2022.05.023 (2022).","journal-title":"Am. J. Ophthalmol."},{"issue":"3","key":"44049_CR46","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/eye.2010.187","volume":"25","author":"RRA Bourne","year":"2011","unstructured":"Bourne, R. R. A. Ethnicity and ocular imaging. Eye 25(3), 297\u2013300. https:\/\/doi.org\/10.1038\/eye.2010.187 (2011).","journal-title":"Eye"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44049-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44049-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44049-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T23:28:56Z","timestamp":1779146936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44049-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["44049"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-44049-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15428"}}